January 30, 2019
Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk
Read More
January 30, 2019
“Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC”
Read More
January 30, 2019
“Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC”
Read More
January 30, 2019
Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques
Read More
January 30, 2019
Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy
Read More
January 30, 2019
Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib
Read More
January 30, 2019
A Study Comparing the Combination of Nivolumab and Ipilimumab Versus Placebo in Participants With Localized Renal Cell Carcinoma
Read More
January 30, 2019
Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma
Read More
January 30, 2019
Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy
Read More
January 30, 2019
Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation
Read More
January 30, 2019
Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients
Read More
Load More
X